AvertD

Call Directions Website

AvertD™ is a clinically validated genetic test that identifies an individual’s risk for developing Opioid Use Disorder (OUD).

05/15/2025

Opioid Use Disorder (OUD) is preventable, and AvertD is designed to help. AvertD is the first and only FDA-authorized genetic test that uses patient DNA to determine whether they have a specific set of genetic variants that may be associated with an elevated genetic risk of developing OUD. By identifying at-risk patients upfront, we can change the trajectory of opioid misuse before it begins.

Learn more about how AvertD is transforming opioid safety: https://avertdtest.com/

04/29/2025

To recognize Laboratory Professionals Week, SOLVD Health honored the incredible work of its lab professionals with a bit of friendly competition and a lot of good food! From our Lab Olympics competition to a great team lunch, it’s been a great reminder of the dedication, talent, and teamwork that drive everything SOLVD Health does.

Thank you to SOLVD Health’s lab team for your precision, passion, and commitment to improving patient care every day!

📸 Swipe through for some of our favorite moments from the week.

01/16/2025

~1 in 6 patients who have an Elevated Genetic Risk may develop OUD after taking oral opioids for acute pain. AvertD® identifies genetic factors associated with an elevated risk of developing opioid use disorder (OUD). This FDA-approved test is rooted in rigorous research, providing healthcare providers with actionable insights to guide safer, more personalized pain management decisions.

Understanding an elevated risk doesn’t mean a patient will develop OUD — it’s about empowering patients and providers to make informed choices before opioids are prescribed.

Learn more about the science behind AvertD® and how it’s shaping the future of preventive care: https://avertdtest.com/

01/12/2025

Today, we celebrate the vital role pharmacists play in safeguarding patient health. Pharmacists can be a first line of defense in ensuring patients understand the risks associated with opioid use and the importance of safer pain management options.

Their dedication to educating patients and supporting informed healthcare decisions is invaluable in the fight against the opioid crisis.

Thank you to pharmacists everywhere for your commitment to improving lives and advancing health!

01/09/2025

Approximately 1 in 16 patients prescribed opioids will use them long-term, significantly increasing their risk for opioid use disorder (OUD). Understanding individual risk is a critical step in preventing opioid misuse and promoting safer pain management.

With patient health outcomes at the forefront, AvertD® empowers healthcare providers to personalize care, support informed decision-making, and help protect patients from potential harm.

Learn more about how AvertD® is shaping the future of personalized care: https://avertdtest.com/

Address

1600 Faraday Avenue
Carlsbad, CA
92008

Telephone

+17605981223

Website

https://avertdtest.com/

Alerts

Be the first to know and let us send you an email when AvertD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed clinic in Carlsbad?